Literature DB >> 15531838

Tyrosinemia type I: a clinico-laboratory case report.

Deepali Karnik1, Niranjan Thomas, C E Eapen, A K Jana, A Oommen.   

Abstract

Progressive hepatocellular dysfunction in a neonate, resulting in elevated serum alpha-fetoprotein together with raised blood levels of tyrosine and methionine, a generalized amino aciduria and the absence of urinary delta-aminolevulinic acid and succinylacetone, suggests a diagnosis of tyrosinemia type Ib. Classical tyrosinemia type I arises from a deficiency of fumarylacetoacetate hydrolase while the variant tyrosinemia type Ib results from a deficiency of maleylacetoacetate isomerase.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531838     DOI: 10.1007/bf02830839

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  9 in total

Review 1.  Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.

Authors:  M St-Louis; R M Tanguay
Journal:  Hum Mutat       Date:  1997       Impact factor: 4.878

Review 2.  The pathophysiology and treatment of hereditary tyrosinemia type 1.

Authors:  M Grompe
Journal:  Semin Liver Dis       Date:  2001-11       Impact factor: 6.115

3.  Neurologic crises in hereditary tyrosinemia.

Authors:  G Mitchell; J Larochelle; M Lambert; J Michaud; A Grenier; H Ogier; M Gauthier; J Lacroix; M Vanasse; A Larbrisseau
Journal:  N Engl J Med       Date:  1990-02-15       Impact factor: 91.245

Review 4.  Tyrosinaemia type I and NTBC (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione).

Authors:  E Holme; S Lindstedt
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

5.  Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada).

Authors:  M De Braekeleer
Journal:  Hum Hered       Date:  1991       Impact factor: 0.444

6.  Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.

Authors:  A Grenier; A Lescault; C Laberge; R Gagné; O Mamer
Journal:  Clin Chim Acta       Date:  1982-08-04       Impact factor: 3.786

7.  Thin-layer chromatography of non-volatile organic acids in clinical chemistry.

Authors:  S Krywawych
Journal:  Clin Chim Acta       Date:  1979-02-01       Impact factor: 3.786

Review 8.  Hereditary tyrosinemia type I--an overview.

Authors:  E A Kvittingen
Journal:  Scand J Clin Lab Invest Suppl       Date:  1986

9.  On the enzymic defects in hereditary tyrosinemia.

Authors:  B Lindblad; S Lindstedt; G Steen
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

  9 in total
  3 in total

1.  Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.

Authors:  Bijo Varughese; Dnyanoba Madrewar; Sunil Kumar Polipalli; Seema Kapoor
Journal:  Indian J Clin Biochem       Date:  2021-01-06

2.  Tyrosinemia: a report of three cases from India.

Authors:  Ira Shah
Journal:  Indian J Gastroenterol       Date:  2013-02-14

3.  Tyrosinemia type I--diagnostic issues and prenatal diagnosis.

Authors:  Sunita Bijarnia; Ratna D Puri; Jean Ruel; George F Gray; Linda Jenkinson; Ishwar C Verma
Journal:  Indian J Pediatr       Date:  2006-02       Impact factor: 1.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.